Back to Treatments

Treatment

Fludarabine + Cyclophosphamide + Rituximab (FCR)

1
Conditions
35
Trials
10K
Participants
28%
Average Safety

Condition Evidence

Chronic lymphoid leukemia

35 trials · 10K participants

80% effectiveness · 28% safety
Fludarabine + Cyclophosphamide + Rituximab (FCR) | DFDA